Directly Observed Antidepressant Medication Treatment and HIV Outcomes Among Homeless and Marginally Housed HIV-positive Adults: a Randomized Controlled Trial

Overview

Journal Am J Public Health

Specialty Public Health

Date 2012 Jun 23

PMID 22720766

Citations 53

Authors

Alexander C Tsai

Dan H Karasic

Gwendolyn P Hammer

Edwin D Charlebois

Kathy Ragland

Andrew R Moss

James L Sorensen

James W Dilley

David R Bangsberg

Affiliations

Soon will be listed here.

Abstract

Objectives: We assessed whether directly observed fluoxetine treatment reduced depression symptom severity and improved HIV outcomes among homeless and marginally housed HIV-positive adults in San Francisco, California, from 2002 to 2008.

Methods: We conducted a nonblinded, randomized controlled trial of once-weekly fluoxetine, directly observed for 24 weeks, then self-administered for 12 weeks (n = 137 persons with major or minor depressive disorder or dysthymia). Hamilton Depression Rating Scale score was the primary outcome. Response was a 50% reduction from baseline and remission a score below 8. Secondary measures were Beck Depression Inventory-II (BDI-II) score, antiretroviral uptake, antiretroviral adherence (measured by unannounced pill count), and HIV-1 RNA viral suppression (< 50 copies/mL).

Results: The intervention reduced depression symptom severity (b = -1.97; 95% confidence interval [CI] = -0.85, -3.08; P < .001) and increased response (adjusted odds ratio [AOR] = 2.40; 95% CI = 1.86, 3.10; P < .001) and remission (AOR = 2.97; 95% CI = 1.29, 3.87; P < .001). BDI-II results were similar. We observed no statistically significant differences in secondary HIV outcomes.

Conclusions: Directly observed fluoxetine may be an effective depression treatment strategy for HIV-positive homeless and marginally housed adults, a vulnerable population with multiple barriers to adherence.

Citing Articles

The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic.

Lesko C, Fojo A, Hutton H, Falade-Nwulia O, Zalla L, Seamans M AIDS. 2024; 39(4):414-423.

PMID: 39591540 PMC: 11864887. DOI: 10.1097/QAD.0000000000004074.

Barriers and facilitators to implementing evidence-based integrated HIV and behavioral health care: perspectives from seven federal ending the HIV epidemic jurisdictions.

McKinnon K, Lentz C, Boccher-Lattimore D, Cournos F, Pather A, Sukumaran S AIDS Care. 2024; 36(11):1555-1562.

PMID: 38771971 PMC: 11511636. DOI: 10.1080/09540121.2024.2354897.

Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations.

Rodriguez M, McLaurin K, Shtutman M, Kubinak J, Mactutus C, Booze R Pharmacol Biochem Behav. 2023; 229:173592.

PMID: 37390973 PMC: 10494709. DOI: 10.1016/j.pbb.2023.173592.

An Intervention to Improve Mental Health and HIV Care Engagement Among Perinatal Women in Malawi: A Pilot Randomized Controlled Trial.

Bengtson A, Filipowicz T, Mphonda S, Udedi M, Kulisewa K, Meltzer-Brody S AIDS Behav. 2023; 27(11):3559-3570.

PMID: 37084104 PMC: 10119837. DOI: 10.1007/s10461-023-04070-8.

Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States.

Koenig L, Khurana N, Islam M, Gopalappa C, Farnham P AIDS. 2023; 37(7):1147-1156.

PMID: 36927810 PMC: 10986188. DOI: 10.1097/QAD.0000000000003536.

References

Smith D, Ghaemi S, Craddock N . The broad clinical spectrum of bipolar disorder: implications for research and practice. J Psychopharmacol. 2008; 22(4):397-400. DOI: 10.1177/0269881108089585. View

Farmer P, Leandre F, Mukherjee J, Gupta R, Tarter L, Kim J . Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull World Health Organ. 2002; 79(12):1145-51. PMC: 2566712. View

Cook J, Grey D, Burke J, Cohen M, Gurtman A, Richardson J . Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004; 94(7):1133-40. PMC: 1448411. DOI: 10.2105/ajph.94.7.1133. View

Frank E, Prien R, Jarrett R, Keller M, Kupfer D, Lavori P . Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991; 48(9):851-5. DOI: 10.1001/archpsyc.1991.01810330075011. View

Altice F, Maru D, Bruce R, Springer S, Friedland G . Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007; 45(6):770-8. PMC: 2693907. DOI: 10.1086/521166. View

Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62. PMC: 495331. DOI: 10.1136/jnnp.23.1.56. View

Herrman H . Mental disorders among homeless people in western countries. PLoS Med. 2008; 5(12):e237. PMC: 2592354. DOI: 10.1371/journal.pmed.0050237. View

Pyne J, Fortney J, Curran G, Tripathi S, Atkinson J, Kilbourne A . Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011; 171(1):23-31. DOI: 10.1001/archinternmed.2010.395. View

Deshauer D, Moher D, Fergusson D, Moher E, Sampson M, Grimshaw J . Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. CMAJ. 2008; 178(10):1293-301. PMC: 2335186. DOI: 10.1503/cmaj.071068. View

10.

Riley E, Gandhi M, Hare C, Cohen J, Hwang S . Poverty, unstable housing, and HIV infection among women living in the United States. Curr HIV/AIDS Rep. 2008; 4(4):181-6. DOI: 10.1007/s11904-007-0026-5. View

11.

Zimmerman M, Mattia J, Posternak M . Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry. 2002; 159(3):469-73. DOI: 10.1176/appi.ajp.159.3.469. View

12.

Zolopa A, Hahn J, Gorter R, Miranda J, Wlodarczyk D, Peterson J . HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA. 1994; 272(6):455-61. View

13.

Page-Shafer K, DeLorenze G, Satariano W, Winkelstein Jr W . Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 1996; 6(5):420-30. DOI: 10.1016/s1047-2797(96)00064-6. View

14.

Gelberg L, Gallagher T, Andersen R, Koegel P . Competing priorities as a barrier to medical care among homeless adults in Los Angeles. Am J Public Health. 1997; 87(2):217-20. PMC: 1380797. DOI: 10.2105/ajph.87.2.217. View

15.

Claxton A, Cramer J, Pierce C . A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23(8):1296-310. DOI: 10.1016/s0149-2918(01)80109-0. View

16.

Burnam M, Bing E, Morton S, Sherbourne C, Fleishman J, London A . Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001; 58(8):729-36. DOI: 10.1001/archpsyc.58.8.729. View

17.

Robertson M, Clark R, Charlebois E, Tulsky J, Long H, Bangsberg D . HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health. 2004; 94(7):1207-17. PMC: 1448423. DOI: 10.2105/ajph.94.7.1207. View

18.

Safren S, OCleirigh C, Tan J, Raminani S, Reilly L, Otto M . A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009; 28(1):1-10. PMC: 2643364. DOI: 10.1037/a0012715. View

19.

Hwang S, Ueng J, Chiu S, Kiss A, Tolomiczenko G, Cowan L . Universal health insurance and health care access for homeless persons. Am J Public Health. 2010; 100(8):1454-61. PMC: 2901287. DOI: 10.2105/AJPH.2009.182022. View

20.

Katon W, Von Korff M, Lin E, Simon G, Ludman E, Russo J . The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004; 61(10):1042-9. DOI: 10.1001/archpsyc.61.10.1042. View